Clinical trial
Effect of Omalizumab in the Skin of Food Allergy Patients
NCT06618963 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Omalizumab in the Skin of Food Allergy Patients
- Lead sponsor
- National Jewish Health
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
food allergy, food allergy in children